ISSN Print: 2381-1277  ISSN Online: 2381-1285
AASCIT Journal of Health  
Manuscript Information
 
 
Mitochondrial Swelling Induced by Redox Imbalance Affects more Liver than Kidney in a Genetic Model of Obese Rat
AASCIT Journal of Health
Vol.4 , No. 1, Publication Date: Sep. 26, 2017, Page: 1-7
735 Views Since September 26, 2017, 712 Downloads Since Sep. 26, 2017
 
 
Authors
 
[1]    

André Soares Trindade, Translational Medicine, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.

[2]    

Priscila Afonso Faria, Center of Natural Sciences and Humanities, Universidade Federal do ABC, Sao Paulo, Brazil.

[3]    

Marcos Antônio Nascimento, Physical Education Section, Brazilian Air Force (FAB), Sao Paulo, Brazil.

[4]    

Giovana Rita Punaro, Nephrology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.

[5]    

Tiago Rodrigues, Center of Natural Sciences and Humanities, Universidade Federal do ABC, Sao Paulo, Brazil.

[6]    

Marcelo Macedo Rogero, Department of Nutrition, Public Health College, Universidade de Sao Paulo, Sao Paulo, Brazil.

[7]    

Elisa Mieko Suemitsu Higa, Translational Medicine, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Nephrology Division, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.

 
Abstract
 

The aim of this study was to evaluate the redox status and mitochondrial function in renal and hepatic tissues (homogenate and isolated mitochondria) of a genetically obese rat. Ten adult male rats were distributed into Zucker (fa-/fa-, n=5) and lean Zucker (fa+/fa-, n=5). Osmotic swelling, reactive oxygen species (ROS), oxidation of thiols and reduced glutathione (GSH) were measured in of renal and hepatic tissues of lean and Zucker rats. The kidney mitochondrial swelling was increased in the obese vs. lean in all concentrations, but it was significant only in Ca+2 (10, 25 or 50 µM); the same was observed in the liver mitochondrial swelling. ROS were significantly increased in liver mitochondria of obese vs. lean, but with no significance statistical in kidney mitochondria. Thiols levels in liver and kidney mitochondrial and homogenate of obese rats did not show statistical differences vs. lean, except in liver homogenate. Obese presented significant reduction of mitochondrial and homogenate GSH levels in kidney and liver vs. lean. These findings demonstrated that obese had higher thiols and ROS and, lower GSH levels, which contributed to mitochondrial dysfunction significant in kidney and liver vs. lean rats. Mitochondrial oxidative stress between obese and lean rats showed difference only in liver; however, the antioxidant system was lower in obese than lean in both, kidney and liver. The results showed that obesity promotes redox imbalance, contributing to mitochondrial dysfunction in both, kidney and liver, being the liver more susceptible than kidney to mitochondria permeabilization, which can be linked to cell death and injury in tissue-specific mitochondrial obesity.


Keywords
 

Mitochondria, ROS, Genetic Obese Rats, Liver, Kidney


Reference
 
[01]    

Persson and PB, Bondke Persson A. Obesity: the BIG issue. Acta Physiol (Oxf). 2013; 207 (1): 1-4.

[02]    

Sowers JR. Diabetes mellitus and vascular disease. Hypertension. 2013; 61 (5): 943-7.

[03]    

Aroor AR, Demarco VG, Jia G, Sun Z, Nistala R, Meininger GA, et al. The Role of Tissue Renin-Angiotensin-Aldosterone System in the Development of Endothelial Dysfunction and Arterial Stiffness. Front Endocrinol (Lausanne). 2013; 4: 161.

[04]    

Jaiswal MK. Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly. Front Cell Neurosci. 2013; 7: 199.

[05]    

Meyers DE, Basha HI, Koenig MK. Mitochondrial Cardiomyopathy: Pathophysiology, Diagnosis, and Management. Tex Heart Inst J. 2013; 40 (4): 385-94.

[06]    

Martin SD, McGee SL. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta. 2013.

[07]    

Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim Biophys Acta. 2013.

[08]    

Ward MS, Fortheringham AK, Cooper ME, Forbes JM. Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease. Curr Opin Pharmacol. 2013; 13 (4): 654-61.

[09]    

Gautier CA, Corti O, Brice A. Mitochondrial dysfunctions in Parkinson's disease. Rev Neurol (Paris). 2013.

[10]    

Jaiman S, Sharma AK, Singh K, Khanna D. Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy. Eur J Clin Pharmacol. 2013; 69 (11): 1863-74.

[11]    

Edeas M, Weissig V. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria. Mitochondrion. 2013; 13 (5): 389-90.

[12]    

Pedersen PL, Greenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, et al. Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol. 1978; 20: 411-81.

[13]    

Cain K, Skilleter DN. Preparation and use of mitochondria in toxicological research. In: Snell K, Mullock B, editors. Biochemical Toxicology: Oxford; 1987. p. 217-54.

[14]    

Jocelyn PC. Spectrophotometric assay of thiols. Methods Enzymol. 1987; 143: 44-67.

[15]    

Dorta DJ, Leite S, DeMarco KC, Prado IM, Rodrigues T, Mingatto FE, et al. A proposed sequence of events for cadmium-induced mitochondrial impairment. J Inorg Biochem. 2003; 97 (3): 251-7.

[16]    

Sadler NC, Angel TE, Lewis MP, Pederson LM, Chauvigne-Hines LM, Wiedner SD, et al. Activity-based protein profiling reveals mitochondrial oxidative enzyme impairment and restoration in diet-induced obese mice. PLoS One. 2012; 7 (10): e47996.

[17]    

Carrer M, Liu N, Grueter CE, Williams AH, Frisard MI, Hulver MW, et al. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc Natl Acad Sci U S A. 2012; 109 (38): 15330-5.

[18]    

Lal N, Rao KR, Suresh P, Islam S, Harishankar N, Giridharan NV, et al. OBESITY ASSOCIATED MITOCHONDRIAL DYSFUNCTION: EVIDENCES FROM WNIN MUTANT RATS. World Journal of Pharmaceutical Research 2015; 4 (3): 1074-96.

[19]    

Vernochet C, Kahn CR. Mitochondria, obesity and aging. Aging (Albany NY). 2012; 4 (12): 859-60.

[20]    

Skulachev VP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q Rev Biophys. 1996; 29 (2): 169-202.

[21]    

Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997; 416 (1): 15-8.

[22]    

Banks AS, Kon N, Knight C, Matsumoto M, Gutierrez-Juarez R, Rossetti L, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. 2008; 8 (4): 333-41.

[23]    

Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun. 2013; 441 (2): 275-9.

[24]    

Dugan LL, You YH, Ali SS, Diamond-Stanic M, Miyamoto S, DeCleves AE, et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest. 2013; 123 (11): 4888-99.

[25]    

Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim Biophys Acta. 2013.

[26]    

Ferrer MD, Sureda A, Mestre A, Tur JA, Pons A. The double edge of reactive oxygen species as damaging and signaling molecules in HL60 cell culture. Cell Physiol Biochem. 2010; 25 (2-3): 241-52.

[27]    

Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012; 19 (1): 107-20.

[28]    

Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009; 390 (3): 191-214.

[29]    

Hargreaves IP, Sheena Y, Land JM, Heales SJ. Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment. J Inherit Metab Dis. 2005; 28 (1): 81-8.

[30]    

Krahenbuhl S, Stucki J, Reichen J. Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis. Hepatology. 1992; 15 (6): 1160-6.

[31]    

Mastrocola R, Restivo F, Vercellinatto I, Danni O, Brignardello E, Aragno M, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol. 2005; 187 (1): 37-44.

[32]    

Benipal B, Lash LH. Influence of renal compensatory hypertrophy on mitochondrial energetics and redox status. Biochem Pharmacol. 2011; 81 (2): 295-303.





 
  Join Us
 
  Join as Reviewer
 
  Join Editorial Board
 
share:
 
 
Submission
 
 
Membership